In the last trading session, 13.63 million Helius Medical Technologies Inc (NASDAQ:HSDT) shares changed hands as the company’s beta touched 0.96. With the company’s per share price at $0.21 changed hands at -$0.13 or -37.92% during last session, the market valuation stood at $0.11M. HSDT’s last price was a discount, traded about -11328.57% off its 52-week high of $24.00. The share price had its 52-week low at $0.30, which suggests the last value was -42.86% down since then. When we look at Helius Medical Technologies Inc’s average trading volume, we note the 10-day average is 15.09 million shares, with the 3-month average coming to 5.97 million.
Analysts gave the Helius Medical Technologies Inc (HSDT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended HSDT as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight.
Helius Medical Technologies Inc (NASDAQ:HSDT) trade information
Instantly HSDT was in red as seen at the end of in last trading. With action -36.06%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -98.62%, with the 5-day performance at -36.06% in the red. However, in the 30-day time frame, Helius Medical Technologies Inc (NASDAQ:HSDT) is -94.12% down. Looking at the short shares, we see there were 2.34 million shares sold at short interest cover period of 0.21 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 63.29%. The 2025 estimates are for Helius Medical Technologies Inc earnings to increase by 92.20%.
HSDT Dividends
Helius Medical Technologies Inc is expected to release its next quarterly earnings report on 2025-May-01.
Helius Medical Technologies Inc (NASDAQ:HSDT)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 17.70% of Helius Medical Technologies Inc shares while 6.31% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 7.67%.
